Summary: The article discusses the potential approval of MDMA for treating posttraumatic stress disorder (PTSD) in the United States based on positive results from clinical trials. If approved, this could …
Quote Originally appearing here (Archived)
“The majority of ketamine clinics do not provide adjunct psychotherapy,” claims Natalie Ginsberg, global impact officer at the Multidisciplinary Association for Psychedelic Studies (Maps), a research …
In 2017, MAPS-sponsored ibogaine researcher Thomas Kingsley Brown took it beyond mice and rats — he conducted his observational study on patients at the La Misión ibogaine clinic in Mexico. And Franciotti …
The bill – HD 2137, by state Rep. Nicholas Boldyga – was introduced in January, apparently in response to reporting by The Washington Post and The New York Times regarding moves by the nonprofit …
Becoming a psychedelic therapist requires vigorous training, psychedelic education, and extreme tenacity to grind through the uncertainty of the legality and creation of this career path. Originally appearing …
Andrew Huberman, PhD (@hubermanlab), is a neuroscientist and tenured professor in the Department of Neurobiology at Stanford University’s School of Medicine. He has made numerous important contributions …
In this conversation, Rick and Isra cover much ground on psychedelics, from set & setting and preparation and integration to Rick’s best practices, personal LSD, MDMA and psilocybin journeys …
You’re having a VR program that’s supposed to somehow remind you of your own inner imagery, so it will be not as precise as your own imagination. -Rick Doblin Originally appearing here (Archived)
In its capacityas afinancial news and media outlet,Benzinga has added six new members to its Psychedelics Advisory Council. The new members includerenowned authorAmanda Siebert; Revitalist Lifestyle & …
Green Bay Packers quarterback Aaron Rodgers and prominent podcaster Tim Ferriss are among thedozens of speakersmaking a trip to Denver this summer for a conference dedicated to all things psychedelics. …
“Australia’s policy change is one that every country should consider: suffering people, regardless of nationality, need more opportunities to access novel treatments,” Rick Doblin, executive director …
